Christopher P. Lowe - Net Worth and Insider Trading

Christopher P. Lowe Net Worth

The estimated net worth of Christopher P. Lowe is at least $278,325 dollars as of 2024-11-08. Christopher P. Lowe is the Interim CEO of Hansen Medical Inc and owns about 42,500 shares of Hansen Medical Inc (HNSN) stock worth over $169,575. Christopher P. Lowe is the COO & CFO of Quince Therapeutics Inc and owns about 60,000 shares of Quince Therapeutics Inc (QNCX) stock worth over $95,934. Christopher P. Lowe is also the Director of Vincerx Pharma Inc and owns about 40,000 shares of Vincerx Pharma Inc (VINC) stock worth over $12,816. Details can be seen in Christopher P. Lowe's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher P. Lowe has not made any transactions after 2022-08-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Christopher P. Lowe

To

Christopher P. Lowe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher P. Lowe owns 6 companies in total, including Quince Therapeutics Inc (QNCX) , Rebus Hldgs Inc (RBSH) , and Hansen Medical Inc (HNSN) among others .

Click here to see the complete history of Christopher P. Lowe’s form 4 insider trades.

Insider Ownership Summary of Christopher P. Lowe

Ticker Comapny Transaction Date Type of Owner
QNCX Quince Therapeutics Inc 2021-10-05 Chief Financial Officer
RBSH Rebus Hldgs Inc 2016-08-03 director & President and CEO
HNSN Hansen Medical Inc 2016-07-27 director & Interim CFO
LIMIT LIMIT 2013-05-17 CFO and Chief Business Officer
LIMIT LIMIT 2020-12-23 director
LIMIT LIMIT 2022-08-25 director

Christopher P. Lowe Latest Holdings Summary

Christopher P. Lowe currently owns a total of 3 stocks. Among these stocks, Christopher P. Lowe owns 42,500 shares of Hansen Medical Inc (HNSN) as of May 20, 2014, with a value of $169,575 and a weighting of 60.93%. Christopher P. Lowe owns 60,000 shares of Quince Therapeutics Inc (QNCX) as of October 5, 2021, with a value of $95,934 and a weighting of 34.47%. Christopher P. Lowe also owns 40,000 shares of Vincerx Pharma Inc (VINC) as of August 25, 2022, with a value of $12,816 and a weighting of 4.6%.

Latest Holdings of Christopher P. Lowe

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HNSN Hansen Medical Inc 2014-05-20 42,500 3.99 169,575
QNCX Quince Therapeutics Inc 2021-10-05 60,000 1.60 95,934
VINC Vincerx Pharma Inc 2022-08-25 40,000 0.32 12,816

Holding Weightings of Christopher P. Lowe


Christopher P. Lowe Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher P. Lowe has made a total of 0 transactions in Hansen Medical Inc (HNSN) over the past 5 years. The most-recent trade in Hansen Medical Inc is the acquisition of 20,000 shares on May 20, 2014, which cost Christopher P. Lowe around $28,800.

According to the SEC Form 4 filings, Christopher P. Lowe has made a total of 2 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Quince Therapeutics Inc is the sale of 4,963 shares on October 5, 2021, which brought Christopher P. Lowe around $488,856.

According to the SEC Form 4 filings, Christopher P. Lowe has made a total of 2 transactions in Vincerx Pharma Inc (VINC) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Vincerx Pharma Inc is the acquisition of 30,000 shares on August 25, 2022, which cost Christopher P. Lowe around $49,500.

Insider Trading History of Christopher P. Lowe

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher P. Lowe Trading Performance

GuruFocus tracks the stock performance after each of Christopher P. Lowe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher P. Lowe is -13.65%. GuruFocus also compares Christopher P. Lowe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher P. Lowe within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher P. Lowe's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher P. Lowe

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.73 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -8.12 LIMIT LIMIT LIMIT LIMIT LIMIT

Christopher P. Lowe Ownership Network

Ownership Network List of Christopher P. Lowe

No Data

Ownership Network Relation of Christopher P. Lowe

Insider Network Chart

Christopher P. Lowe Owned Company Details

What does Quince Therapeutics Inc do?

Who are the key executives at Quince Therapeutics Inc?

Christopher P. Lowe is the Chief Financial Officer of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include director & Chief Executive Officer Dirk Thye , Chief Business Officer Brendan Hannah , and President Charles S. Ryan .

Quince Therapeutics Inc (QNCX) Insider Trades Summary

Over the past 18 months, Christopher P. Lowe made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 241,811 shares, with a net purchase of 241,811 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Quince Therapeutics Inc Insider Transactions

No Available Data

Christopher P. Lowe Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher P. Lowe. You might contact Christopher P. Lowe via mailing address: 2511 N Loop 1604,, Suite 204, San Antonio Tx 78258.